DailyDoctor Archive Specialties Get app
All internal medicine briefings

The edition · Internal Medicine

Endoscopy within six hours did not improve outcomes in non-variceal upper GI bleeding

A meta-analysis of 10,785 patients found ultra-early endoscopy no better than endoscopy within 24 hours, even in high-risk bleeders; a potassium-competitive acid blocker lifted H. pylori eradication where clarithromycin resistance is documented; and a referral trial in prostate cancer improved cholesterol, not cardiac events.

The edition in brief

Nine studies of 10,785 adults with non-variceal upper gastrointestinal bleeding compared endoscopy within six hours against later endoscopy within the usual window. Ultra-early endoscopy did not reduce mortality (OR 0.88, 95% CI 0.58–1.34) or rebleeding (OR 1.23, 0.90–1.67), including in high-risk patients, and was associated with more ICU admission; resuscitation first, then endoscopy within 24 hours, remains the target. In an international trial of 2,487 men starting androgen deprivation therapy for prostate cancer, routine referral to an internist or cardiologist improved a hierarchical composite (win ratio 1.60), almost entirely by lowering cholesterol with protocol statins; cardiovascular death, MI, stroke and heart failure did not differ. A retrospective cohort from a 714-bed US academic centre found that encounters needing post-acute care referral accounted for 85.5% of excess hospital days. And a meta-analysis of patients with documented clarithromycin-resistant H. pylori found eradication in 74.7% with potassium-competitive acid blocker regimens versus 52.7% with proton pump inhibitor regimens (RR 1.42), strongest with vonoprazan.

In this edition
01
Clinical update

Ultra-early endoscopy did not reduce death or rebleeding in non-variceal upper GI bleeding

In non-variceal upper GI bleeding, resuscitate well and scope within 24 hours; endoscopy within six hours does not improve outcomes, even in high-risk patients.

2 min · PeerJRead →
Primary outcome
Mortality and rebleeding
Effect
Mortality OR 0.88 (95% CI 0.58–1.34); rebleeding OR 1.23 (0.90–1.67); ICU admission OR 1.41 (1.20–1.66)
02Research

Routine cardiovascular referral at the start of androgen deprivation lowered cholesterol but not events

Treat cardiovascular risk factors in men on androgen deprivation therapy, but routine specialist referral did not reduce heart attacks, strokes or heart failure.

2 min · JAMA internal medicineRead →
03Research

Patients needing post-acute care referral accounted for 85% of excess hospital days

Start discharge planning on admission for patients likely to need post-acute care — they carry most of the avoidable hospital days.

1 min · Journal of hospital medicineRead →
04Pearl

Glasgow-Blatchford 0–1: the upper GI bleed who can go home

Patients with a Glasgow-Blatchford score of 0–1 can usually have outpatient endoscopy rather than admission.

1 minRead →
05Practice changer

Vonoprazan-based regimens eradicated clarithromycin-resistant H. pylori far more often than PPI regimens

When treating H. pylori where clarithromycin resistance is likely, swap the PPI for a P-CAB such as vonoprazan if available — and prefer a regimen without clarithromycin.

2 min · Pathogens (Basel, Switzerland)Read →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free